Home

Cluster 2NXL T3 A75

The binding interfaces of the superposed protein-peptide complexes are shown in grey, the peptides in red. Images produced by YASARA. Note that only the interface of the protein-peptide complexes is shown. Gaps between residues may occur.

Properties of this cluster

2NXL
15
3 Å
75 %
Properties of this cluster. Learn more about the clustering methodology.

Protein-peptide complexes in this cluster

Showing 1-10 of 15 results
PDB ID Description
2NXD Structure of HIV-1 protease D25N complexed with rt-rh analogue peptide GLY-ALA-ASP-ILE-PHE*TYR-LEU-ASP-GLY-ALA
1KJG SUBSTRATE SHAPE DETERMINES SPECIFICITY OF RECOGNITION RECOGNITION FOR HIV-1 PROTEASE: ANALYSIS OF CRYSTAL STRUCTURES OF SIX SUBSTRATE COMPLEXES
2FNS Crystal structure of wild-type inactive (D25N) HIV-1 protease complexed with wild-type HIV-1 NC-p1 substrate.
1SP5 Crystal structure of HIV-1 protease complexed with a product of autoproteolysis
2NXL Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLU-VAL-PHE*TYR-VAL-ASP-GLY-ALA
1MT7 Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy
1TSQ CRYSTAL STRUCTURE OF AP2V SUBSTRATE VARIANT OF NC-P1 DECAMER PEPTIDE IN COMPLEX WITH V82A/D25N HIV-1 PROTEASE MUTANT
2FNT Crystal structure of a drug-resistant (V82A) inactive (D25N) HIV-1 protease complexed with AP2V variant of HIV-1 NC-p1 substrate.
2NXM Structure of HIV-1 protease D25N complexed with the rt-rh analogue peptide GLY-ALA-GLN-THR-PHE*TYR-VAL-ASP-GLY-ALA
1MT8 Viability of a drug-resistant HIV-1 protease mutant: structural insights for better antiviral therapy